{"id":35875,"date":"2025-10-07T15:11:31","date_gmt":"2025-10-07T13:11:31","guid":{"rendered":"https:\/\/ggba.swiss\/?p=35875"},"modified":"2025-10-07T15:11:32","modified_gmt":"2025-10-07T13:11:32","slug":"ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/","title":{"rendered":"UCB invests over CHF 100 million to expand its biopharmaceutical site in Bulle"},"content":{"rendered":"\n<p>Biopharmaceutical company <a href=\"https:\/\/www.ucb.com\/\">UCB<\/a> has announced a major investment plan of more than CHF 100 million to expand and modernize its industrial site in Bulle (canton of Fribourg). The projects, spread over several years, aim to reinforce infrastructure, increase production capacity, and enhance operational efficiency to support the group\u2019s long-term growth strategy.<\/p>\n\n\n\n<p>By 2030, around 80 new jobs will be created to support operations at a new production unit currently under construction. The positions will include roles in manufacturing, quality control laboratories, and technical services.<\/p>\n\n\n\n<p>As part of this expansion, UCB will transfer to Bulle the production of a chemical compound used in some of its biological medicines, currently manufactured at its Belgian site in Braine-l\u2019Alleud. The relocation is designed to secure long-term supply of the compound and optimize production efficiency across sites.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Modernized laboratories and sustainable infrastructure<\/h4>\n\n\n\n<p>Construction of the new unit began in September and involves close collaboration with local partners. The new facility will be integrated within an existing chemical production building, making the project particularly complex. UCB expects the unit to be fully qualified and approved by 2029, with commercial production ramping up to full capacity by 2030.<\/p>\n\n\n\n<p>In parallel, UCB is extending its analytical laboratories and establishing a new Quality Control laboratory, scheduled to be operational by mid-2026. The company is also building a new industrial cooling facility to centralize cold production for the entire site.<\/p>\n\n\n\n<p>The new hall will replace traditional refrigerants with environmentally friendly alternatives, aligning with UCB\u2019s sustainability strategy to improve energy efficiency and reduce its carbon footprint.<br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>UCB is investing more than CHF 100 million in its Bulle site to boost capacity, create new jobs, and strengthen sustainable production.<\/p>\n","protected":false},"author":6,"featured_media":35876,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[912,1011,918,929,911],"class_list":["post-35875","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-biotech","tag-infrastructures","tag-investment","tag-manufacturing","tag-pharma"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>UCB invests over CHF 100 million to expand its site in Bulle<\/title>\n<meta name=\"description\" content=\"UCB is investing more than CHF 100 million in its Bulle site to boost capacity, create new jobs, and strengthen sustainable production.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UCB invests over CHF 100 million to expand its site in Bulle\" \/>\n<meta property=\"og:description\" content=\"UCB is investing more than CHF 100 million in its Bulle site to boost capacity, create new jobs, and strengthen sustainable production.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-07T13:11:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-07T13:11:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/UCB-Farchim-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"UCB invests over CHF 100 million to expand its biopharmaceutical site in Bulle\",\"datePublished\":\"2025-10-07T13:11:31+00:00\",\"dateModified\":\"2025-10-07T13:11:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/\"},\"wordCount\":265,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/UCB-Farchim-1180x811-1.jpeg\",\"keywords\":[\"Biotech\",\"Infrastructures\",\"Investment\",\"Manufacturing\",\"Pharma\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/\",\"url\":\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/\",\"name\":\"UCB invests over CHF 100 million to expand its site in Bulle\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/UCB-Farchim-1180x811-1.jpeg\",\"datePublished\":\"2025-10-07T13:11:31+00:00\",\"dateModified\":\"2025-10-07T13:11:32+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"UCB is investing more than CHF 100 million in its Bulle site to boost capacity, create new jobs, and strengthen sustainable production.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/UCB-Farchim-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/UCB-Farchim-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"UCB\u2019s Bulle site will gain new production, laboratory, and energy facilities as part of a CHF 100 million investment plan. | \u00a9 UCB\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UCB invests over CHF 100 million to expand its biopharmaceutical site in Bulle\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UCB invests over CHF 100 million to expand its site in Bulle","description":"UCB is investing more than CHF 100 million in its Bulle site to boost capacity, create new jobs, and strengthen sustainable production.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/","og_locale":"en_US","og_type":"article","og_title":"UCB invests over CHF 100 million to expand its site in Bulle","og_description":"UCB is investing more than CHF 100 million in its Bulle site to boost capacity, create new jobs, and strengthen sustainable production.","og_url":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-10-07T13:11:31+00:00","article_modified_time":"2025-10-07T13:11:32+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/UCB-Farchim-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"UCB invests over CHF 100 million to expand its biopharmaceutical site in Bulle","datePublished":"2025-10-07T13:11:31+00:00","dateModified":"2025-10-07T13:11:32+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/"},"wordCount":265,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/UCB-Farchim-1180x811-1.jpeg","keywords":["Biotech","Infrastructures","Investment","Manufacturing","Pharma"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/","url":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/","name":"UCB invests over CHF 100 million to expand its site in Bulle","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/UCB-Farchim-1180x811-1.jpeg","datePublished":"2025-10-07T13:11:31+00:00","dateModified":"2025-10-07T13:11:32+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"UCB is investing more than CHF 100 million in its Bulle site to boost capacity, create new jobs, and strengthen sustainable production.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/UCB-Farchim-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/UCB-Farchim-1180x811-1.jpeg","width":1180,"height":811,"caption":"UCB\u2019s Bulle site will gain new production, laboratory, and energy facilities as part of a CHF 100 million investment plan. | \u00a9 UCB"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/ucb-invests-over-chf-100-million-to-expand-its-biopharmaceutical-site-in-bulle\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"UCB invests over CHF 100 million to expand its biopharmaceutical site in Bulle"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/35875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=35875"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/35875\/revisions"}],"predecessor-version":[{"id":35879,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/35875\/revisions\/35879"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/35876"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=35875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=35875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=35875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}